User profiles for Katja Schenke-Layland

Katja Schenke-Layland

Eberhard Karls University Tübingen, NMI Reutlingen
Verified email at uni-tuebingen.de
Cited by 13670

Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering

S Heydarkhan-Hagvall, K Schenke-Layland… - Biomaterials, 2008 - Elsevier
Electrospinning using natural proteins or synthetic polymers is a promising technique for the
fabrication of fibrous scaffolds for various tissue engineering applications. However, one …

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages

K Schenke-Layland, KE Rhodes, E Angelis… - Stem …, 2008 - academic.oup.com
Forced expression of the four transcription factors Oct4, Sox2, c-Myc, and Klf4 is sufficient to
confer a pluripotent state upon the murine fibroblast genome, generating induced pluripotent …

Skin tissue engineering—in vivo and in vitro applications

…, M Hampel, S Hinderer, K Schenke-Layland - Advanced drug delivery …, 2011 - Elsevier
Significant progress has been made over the years in the development of in vitro-engineered
substitutes that mimic human skin, either to be used as grafts for the replacement of lost …

[HTML][HTML] Cardiac fibrosis–a short review of causes and therapeutic strategies

S Hinderer, K Schenke-Layland - Advanced drug delivery reviews, 2019 - Elsevier
Fibrotic diseases cause annually more than 800,000 deaths worldwide, whereof the majority
accounts for lung and cardiac fibrosis. A pathological remodeling of the extracellular matrix …

[HTML][HTML] Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

…, J Held, H Planatscher, K Schenke-Layland… - Nature …, 2021 - nature.com
SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …

[HTML][HTML] ECM and ECM-like materials—Biomaterials for applications in regenerative medicine and cancer therapy

S Hinderer, SL Layland, K Schenke-Layland - Advanced drug delivery …, 2016 - Elsevier
Regenerative strategies such as stem cell-based therapies and tissue engineering applications
are being developed with the aim to replace, remodel, regenerate or support damaged …

[HTML][HTML] Human heart-forming organoids recapitulate early heart and foregut development

…, H Kempf, S Liebscher, K Schenke-Layland… - Nature …, 2021 - nature.com
Organoid models of early tissue development have been produced for the intestine, brain,
kidney and other organs, but similar approaches for the heart have been lacking. Here we …

Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells

…, Y Zhu, K Schenke-Layland… - Proceedings of the …, 2010 - National Acad Sciences
Our understanding of how mesodermal tissue is formed has been limited by the absence of
specific and reliable markers of early mesoderm commitment. We report that mesoderm …

Mapping human haematopoietic stem cells from haemogenic endothelium to birth

…, EG Stanley, AG Elefanty, K Schenke-Layland… - Nature, 2022 - nature.com
The ontogeny of human haematopoietic stem cells (HSCs) is poorly defined owing to the
inability to identify HSCs as they emerge and mature at different haematopoietic sites 1 . Here …

[PDF][PDF] Self-organized cerebral organoids with human-specific features predict effective drugs to combat Zika virus infection

…, R Aliyari, S Liebscher, K Schenke-Layland… - Cell reports, 2017 - cell.com
The human cerebral cortex possesses distinct structural and functional features that are not
found in the lower species traditionally used to model brain development and disease. …